Onderneming Arcadia Biosciences Inc Nasdaq
Aandelen
US0390141051
Landbouwchemicaliën
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Plant-based Food and Beverage
99,7
%
| 9 | 90,0 % | 5 | 99,7 % | -40,70% |
License
0,3
%
| 1 | 8,8 % | 0 | 0,3 % | -98,07% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
94,4
%
| 9 | 88,8 % | 5 | 94,4 % | -43,05% |
Canada
5,5
%
| 0 | 1,9 % | 0 | 5,5 % | +50,00% |
India
0,1
%
| 0 | 0,1 % | 0 | 0,1 % | -.--% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stanley Jacot
CEO | Chief Executive Officer | 54 | 02-02-22 |
Thomas Schaefer
DFI | Director of Finance/CFO | 48 | 01-07-20 |
Kevin Comcowich
CHM | Chairman | 55 | 01-11-16 |
Brett Michel
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Amy Yoder
BRD | Director/Board Member | 56 | 10-08-17 |
Gregory Waller
BRD | Director/Board Member | 74 | 13-06-17 |
Kevin Comcowich
CHM | Chairman | 55 | 01-11-16 |
Lilian S. Murray
BRD | Director/Board Member | 65 | 01-06-18 |
Albert Bolles
BRD | Director/Board Member | 66 | 16-05-18 |
Debbie Carosella
BRD | Director/Board Member | 67 | 22-02-21 |
Stanley Jacot
CEO | Chief Executive Officer | 54 | 02-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 362 840 | 1 327 434 ( 97,40 %) | 0 | 97,40 % |
Bedrijfsgegevens
Arcadia Biosciences, Inc.
5950 Sherry Lane Suite 215
75225, Dallas
+214 974 8921
http://www.arcadiabio.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,91% | 37,68 mld. | |
-4,00% | 7,21 mld. | |
+3,64% | 6,64 mld. | |
-5,50% | 5,86 mld. | |
-3,05% | 5,69 mld. | |
-11,31% | 5,54 mld. | |
+29,81% | 5,13 mld. | |
-15,16% | 4,56 mld. | |
+7,72% | 3,87 mld. |